ChemicalBook > CAS DataBase List > Lomeguatrib

Lomeguatrib

Product Name
Lomeguatrib
CAS No.
192441-08-0
Chemical Name
Lomeguatrib
Synonyms
C521206;CS-1103;AI3 27596;BRN1861032;Lomeguatrib;Lomeguqtrib;BRN 1861032;BRN-1861032;Lomeguaritrib;Lomeguatrib, >=98%
CBNumber
CB11261272
Molecular Formula
C10H8BrN5OS
Formula Weight
326.17
MOL File
192441-08-0.mol
More
Less

Lomeguatrib Property

Boiling point:
683.8±65.0 °C(Predicted)
Density 
2.07
storage temp. 
Keep in dark place,Inert atmosphere,2-8°C
solubility 
DMSO: soluble10mg/mL, clear
pka
9.42±0.10(Predicted)
form 
powder
color 
white to beige
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
More
Less

Safety

Hazard Codes 
Xn
Risk Statements 
22
WGK Germany 
3
RTECS 
UO7420000
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML0586
Product name
Lomeguatrib
Purity
≥98% (HPLC)
Packaging
5mg
Price
$128
Updated
2024/03/01
Sigma-Aldrich
Product number
SML0586
Product name
Lomeguatrib
Purity
≥98% (HPLC)
Packaging
25mg
Price
$397
Updated
2024/03/01
Cayman Chemical
Product number
11732
Product name
Lomeguatrib
Purity
≥98%
Packaging
5mg
Price
$38
Updated
2024/03/01
Cayman Chemical
Product number
11732
Product name
Lomeguatrib
Purity
≥98%
Packaging
10mg
Price
$67
Updated
2024/03/01
Cayman Chemical
Product number
11732
Product name
Lomeguatrib
Purity
≥98%
Packaging
25mg
Price
$146
Updated
2024/03/01
More
Less

Lomeguatrib Chemical Properties,Usage,Production

Description

Lomeguatrib (192441-08-0) is a potent (IC50?= 9 nM) inhibitor of O6-Methylguanine-DNA Methyltransferase (MGMT), an important DNA repair protein.1?It is currently being investigated in cancers that have acquired resistant to the chemotherapeutic temozolomide2-5, as well as other chemotherapeutics6,7.

Uses

O6-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair protein which removes an alkyl group from the O6 position on guanine in an autoinactivating reaction. Although important in normal DNA repair, this reaction confers resistance to treatments that use O6-alkylating agents to produce cytotoxicity, e.g., in cancer. Lomeguatrib is a modified quanine base which acts as a pseudosubstrate inactivator of MGMT (IC50 = ~3 nM). A non-toxic compound, lomeguatrib completely inactivates MGMT in human prostate and colorectal tumors when given as a single 120 mg oral dose and in primary central nervous system cancers at 160 mg.

Uses

Lomeguatrib is an inhibitor of O6-methylguanine-DNA methyltransferase (MGMT). Lomeguatrib attenuates MGMT activity in vitro and in vivo. Lomeguatrib enhances the antitumor activity of temozolomide in both human melanoma and MCF-7 xenografts.

storage

+4°C

References

1) Reinhard?et al.?(2001),?Monosaccharide-Linked Inhibitors of O6-Methylguanine-DNA Methyltransferase (MGMT): Synthesis, Molecular Modeling, and Structure-Activity Relationships; J. Med. Chem.?44?4050 2) Barvaux?et al.?(2004),?Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase: Mol. Cancer Ther.?3?1215 3) Gumbrell?et al.?(2006),?Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors: Clin. Cancer Res.?12?1577 4) Watson?et al.?(2009),?O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib: Br. J. Cancer?100?1250 5) Taspinar?et al.?(2013),?Effect of lomeguatrib-temozolomide combination of MGMT promoter methylation and expression in primary glioblastoma tumor cells: Tumour Biol.?34?1935 6) Sabharwal?et al.?(2010),?A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer: Cancer Chemother. Pharmacol.?66?829 7) Tawbi?et al.?(2011),?Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumors: Br. J. Cancer?105?773

Lomeguatrib Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lomeguatrib Suppliers

Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
ZHIWE CHEMTECH CO LTD
Tel
021-20221225 13917446399
Fax
QQ:115820162
Email
sales@zhiwe.net
Country
China
ProdList
627
Advantage
61
VDM Biochemicals
Tel
0330-2528181
Fax
0330-2528171
Email
sales@vdmbio.com
Country
United States
ProdList
510
Advantage
64
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15402
Advantage
60
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Fax
+86 (531) 55696010 QQ 1762738062
Email
sales@trio-pharmatech.com (International market)
Country
China
ProdList
1856
Advantage
62
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Country
China
ProdList
4727
Advantage
58
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Fax
+86 21 50676805
Country
China
ProdList
9891
Advantage
58
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-400-6206333 18521732826
Fax
021-50323701
Email
market@aladdin-e.com
Country
China
ProdList
25003
Advantage
65

192441-08-0, LomeguatribRelated Search:


  • Lomeguatrib
  • 2-Amino-6-[(4-bromo-2-thienyl)methoxy]-9H-purine
  • 6-[(4-bromothiophen-2-yl)methoxy]-7H-purin-2-amine
  • 6-((4-Bromo-2-thienyl)methoxy)purin-2-amine
  • C521206
  • 2-AMino-6-(4-broMothiophen-2-ylMethoxy)-9H-purine
  • 6-[(4-BroMo-2-thienyl)Methoxy] -1H-purin-2-aMine
  • 6-[(4-BroMo-2-thienyl)Methoxy]-9H-purin-2-aMine
  • LoMeguatrib(PaTrin-2)
  • 2-Amino-6-[(4-bromo-2-thienyl)methoxy]-9H-purine Lomeguatrib(PaTrin-2)
  • 2-Amino-6-[(4-bromo-2-thienyl)methoxy]-9H-purine Lomeguatrib
  • Lomeguatrib 2-Amino-6-[(4-bromo-2-thienyl)methoxy]-9H-purine
  • Lomeguqtrib
  • Lomeguaritrib
  • Lomeguatrib, >=98%
  • CS-1103
  • PATRIN 2; PATRIN-2
  • 9H-Purin-2-amine, 6-[(4-bromo-2-thienyl)methoxy]-
  • Lomeguatrib USP/EP/BP
  • 6-((4-Bromothiophen-2-yl)methoxy)-9H-purin-2-amine
  • AI3 27596
  • BRN 1861032
  • BRN1861032
  • BRN-1861032
  • 192441-08-0
  • C10H8BrN5OS
  • Inhibitors
  • Inhibitor of MGMT.
  • Epigenetics